Company Filing History:
Years Active: 2021
Title: Innovations by Julianne Jorgensen in Microfluidic Technology
Introduction
Julianne Jorgensen is an accomplished inventor based in Somerville, MA (US). She has made significant contributions to the field of microfluidics, particularly in the area of disease detection. Her innovative work focuses on the behavior of neutrophils, which are crucial in the immune response.
Latest Patents
Julianne holds a patent for "Microfluidic neutrophil assays and systems for disease detection." This patent relates to microfluidic devices and methods that monitor the directionality, velocity, and migration persistence of neutrophils or other cells without chemical gradients. The technology is designed to detect and quantify abnormal neutrophil motility phenotypes using low sample volumes and minimal activation of the neutrophils. This invention has significant implications for diagnosing sepsis in patients suspected of having the condition or at risk of developing it. Additionally, the devices and methods can be utilized to monitor patient responses to sepsis therapies. She has 1 patent to her name.
Career Highlights
Julianne is associated with The General Hospital Corporation, where she continues to advance her research and innovations. Her work has garnered attention for its potential to improve diagnostic methods in clinical settings.
Collaborations
Julianne collaborates with notable colleagues, including Daniel Irimia and Felix Ellett, who contribute to her research endeavors and enhance the impact of her inventions.
Conclusion
Julianne Jorgensen's innovative work in microfluidic technology represents a significant advancement in disease detection, particularly for conditions like sepsis. Her contributions are paving the way for improved diagnostic tools that can benefit patient care.